[조사 보고서] 세계의 의약품 시장 (2023-2030) : 분자 유형별, 제품별, 종류별, 질환별, 제형별, 연령대별, 투여 경로별, 최종 시장별, 지역별

■ 영문 제목 : Pharmaceutical Market Size, Share & Trends Analysis Report By Molecule Type, By Product, By Type, By Disease, By Formulation, By Age Group, By Route Of Administration, By End Market, By Region, And Segment Forecasts, 2023 - 2030
	■ 상품코드 : GRV24JNU037 ■ 조사/발행회사 : Grand View Research ■ 발행일 : 2023년 12월 ■ 페이지수 : 250 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (납기 : 3일) ■ 조사대상 지역 : 세계 ■ 산업 분야 : 의약품

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD5,950 ⇒환산￦8,032,500	견적의뢰/주문/질문
Multi User (5인 열람용)	USD6,950 ⇒환산￦9,382,500	견적의뢰/주문/질문
Global/corporate License (기업 열람용)	USD8,950 ⇒환산￦12,082,500	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 의약품 시장의 성장과 동향

Grand View Research, Inc.사의 최신 보고서에 따르면, 세계의 의약품 시장 규모는 2023년부터 2030년까지 연평균 6.12%의 성장률로 확대되어 2030년에는 2조 2,3632.5억 달러에 이를 것으로 예측됩니다. 의약품 시장의 성장은 만성질환의 증가와 새로운 치료제 개발에 대한 수요 증가에 기인하며, National Council on Aging에 따르면 노인 인구의 약 95%가 적어도 한 가지 이상의 만성질환을 앓고 있으며, 약 80%는 두 가지 이상의 만성질환을 앓고 있는 것으로 추정되고 있습니다. 또한, 당뇨병, 관절염, 심장병과 같은 만성질환은 노인 인구에 불균형적으로 영향을 미치고 있습니다.

예방, 조기 발견, 집중 치료 및 효과적인 치료를 위해서는 인식이 중요합니다. 질병과 그 증상을 알고 있는 사람들은 검진, 검사, 건강검진 등 예방 조치를 취하는 경향이 강합니다. 다양한 질병에 대한 인식이 높아지는 것도 제약 분야를 견인하는 요소입니다. 암이나 당뇨병과 같은 질병에 대한 사람들의 인식이 높아짐에 따라, 질병에 걸렸을 때 치료를 받을 확률이 높아졌습니다. 공공 기관과 민간 단체는 국민들에게 인식을 확산하고 교육하기 위해 다양한 노력을 기울이고 있습니다. 또한, 많은 사람들이 처방약 비용을 보장하는 보험에 가입하면서 의약품 수요 증가에 기여하고 있습니다.

또한, 새로운 치료제 개발의 기술 발전으로 인해 전 세계적으로 의약품 수요가 크게 증가하고 있습니다. 제약업계는 연구개발뿐만 아니라 제품 판매와 유통에도 전례 없는 속도로 투자하고 있습니다. 이 산업은 사람들의 건강에 직접적으로 영향을 미치는 데 초점을 맞추고 있습니다. 제약 산업은 환자 치료와 지역 사회 발전에 필수적이며, 수많은 생명을 구하는 치료법을 제공하고, 고용을 창출하며, 세계 경제에 기여하고 있습니다.

백신 제조, 발효 공정 및 생명공학에는 박테리아와 바이러스를 포함한 많은 생물학적 제제가 사용됩니다. 이 시장은 거대 제약사, 중견 특수 제약사, 가상 제약사, 제네릭 제조업체, 소규모 생명공학 및 바이오 의약품 기업 등 다양한 기업으로 구성되어 있습니다. 또한, 다양한 치료용 제제 개발 및 제형화에 관여하는 주요 기업들은 신약 개발 및 시장 경쟁력 유지를 위해 공동 연구 및 제휴에 주력하고 있습니다.

또한, 증상 예방 및 치료에 대한 수요 증가에 대응하기 위해 여러 기업이 신약 개발에 매진하고 있습니다. 예를 들어, 2023년 4월 F. Hoffmann-La Roche는 2022년 1월 FDA 승인을 받은 자사의 습성 노화성 황반변성 치료제 Vabysmo가 2023년 1분기에 약 5억 달러의 매출을 올렸다고 발표했습니다. 이 약의 매출은 전년 동기 대비 500% 이상 증가해 다발성 경화증 치료제 오크레바스, 혈우병 치료제 헴리브라 등 경쟁 약물을 능가했습니다. 또한, 노바티스 AG는 2023년 7월 미국 FDA로부터 레쿠비오(성분명: 인크레실란)의 적응증 확대에 대해 심장병 위험이 높은 고(高)LDL-C환자 치료까지 포함하도록 승인받았습니다.

의약품 시장 보고서 주요 내용

- 분자 유형별로는 기존 의약품이 전체 시장을 주도하고 있습니다. 제약 시장에서 전통적 의약품의 우위는 확립된 제조 공정, 예측 가능한 약동학, 경구용 생체이용률에 기인합니다.

■ 보고서 개요

1. 조사 방법 및 범위
2. 개요
3. 세계의 의약품 시장 변수, 동향, 범위
4. 세계의 의약품 시장 규모 : 분자 유형별 예측 및 동향 분석
5. 세계의 의약품 시장 규모 : 제품별 예측 및 동향 분석
6. 세계의 의약품 시장 규모 : 유형별 예측 및 동향 분석
7. 세계의 의약품 시장 규모 : 질환별 예측 및 동향 분석
8. 세계의 의약품 시장 규모 : 투여 경로별 예측 및 동향 분석
9. 세계의 의약품 시장 규모 : 제제별 예측 및 동향 분석
10. 세계의 의약품 시장 규모 : 연령별 예측 및 동향 분석
11.세계의 의약품 시장 규모 : 최종 시장별 예측 및 동향 분석
12. 세계의 의약품 시장 규모 : 지역별 비즈니스 분석
13. 경쟁 현황

■ 보고서 목차

Table of Contents

Chapter 1. Pharmaceutical Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective – 1
1.4.2. Objective – 2
1.4.3. Objective – 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations
Chapter 2. Pharmaceutical Market: Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Pharmaceutical Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Increasing healthcare spending by the government
3.2.1.2. Improving affordability driven by rising per capita income
3.2.1.3. Increasing awareness about healthcare among the population
3.2.1.4. Increasing access to innovative and modern medicines
3.2.1.5. Demographic and lifestyle changes leading to rising prevalence of chronic diseases
3.2.1.6. Rising chronic diseases and geriatric population
3.2.2. Market Restraint Analysis
3.2.2.1. COVID – 19 pandemic
3.2.2.2. Intensification of competition from generic and biosimilar drugs
3.2.2.3. Increasing price – sensitivity of customers for non – reimbursed drugs
3.2.2.4. Increasing barriers to market access and decreasing R&D productivity of pharma companies
3.3. Porter’s Five Forces Analysis
3.4. PESTLE Analysis
Chapter 4. Pharmaceutical Market: Molecule Type Outlook Estimates & Trend Analysis
4.1. Molecule Type Outlook: Movement Analysis
4.2. Biologics & Biosimilars (Large Molecules)
4.2.1. Biologics & Biosimilars Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
4.2.1.1 Monoclonal Antibodies
4.2.1.2 Monoclonal Antibodies Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
4.2.2.3 Vaccines
4.2.2.4 Vaccines Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
4.2.3.5 Cell & Gene Therapy
4.2.3.6 Cell & Gene Therapy Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
4.2.4.7 Others
4.2.4.8 Others Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
4.3. Conventional Drugs (Small Molecules)
4.3.1. Conventional Drugs Market Estimates And Forecasts, 2018 – 2030 (USD Billion)
Chapter 5. Pharmaceutical Market: Product Estimates & Trend Analysis
5.1. Pharmaceutical Market: Product Movement Analysis
5.2. Branded
5.2.1. Branded Product Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
5.3. Generic
5.3.1. Generic Product Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
Chapter 6. Pharmaceutical Market: Type Estimates & Trend Analysis
6.1. Pharmaceutical Market: Type Movement Analysis
6.2. Prescription
6.2.1. Prescription Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
6.3. OTC
6.3.1. OTC Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
Chapter 7. Pharmaceutical Market: Diseases Outlook Estimates & Trend Analysis
7.1. Pharmaceutical Market: Diseases Outlook Movement Analysis
7.2. Cardiovascular diseases
7.2.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.3. Cancer
7.3.1. Cancer Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.4. Diabetes
7.4.1. Diabetes Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.5. Infectious diseases
7.5.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.6. Neurological disorders
7.6.1. Neurological Disorders Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.7. Respiratory diseases
7.7.1. Respiratory Diseases Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.8. Autoimmune diseases
7.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.9. Mental health disorders
7.9.1. Mental Health Disorders Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.10. Gastrointestinal disorders
7.10.1. Gastrointestinal Disorders Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.11. Women’s Health Diseases
7.11.1. Women’s Health Diseases Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.12. Genetic and Rare genetic diseases
7.12.1. Genetic and Rare Genetic Diseases Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.13. Dermatological conditions
7.13.1. Dermatological Conditions Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.14. Obesity
7.14.1. Obesity Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.15. Renal diseases
7.15.1. Renal Diseases Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.17. Liver conditions
7.17.1. Liver Conditions Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.17. Hematological disorders
7.17.1. Hematological Disorders Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.18. Eye conditions
7.18.1. Eye Conditions Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.19. Infertility conditions
7.19.1. Infertility Conditions Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.20. Endocrine disorders
7.20.1. Endocrine Disorders Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.21. Allergies
7.21.1. Allergies Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
7.22. Others
7.22.1. Others Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
Chapter 8. Pharmaceutical Market: Route of Administration Estimates & Trend Analysis
8.1. Pharmaceutical Market: Route of Administration Movement Analysis
8.2. Oral
8.2.1. Oral Route Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
8.3. Topical
8.3.1. Topical Route Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
8.4. Parenteral
8.4.1. Parenteral Route Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
8.4.1.1. Intravenous
8.4.1.2. Intramuscular
8.5. Inhalations
8.5.1. Inhalations Route Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
8.6. Other
8.6.1. Other Routes Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
Chapter 9. Pharmaceutical Market: Formulation Estimates & Trend Analysis
9.1. Pharmaceutical Market: Formulation Movement Analysis
9.2. Tablets
9.2.1. Tablets Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
9.3. Capsules
9.3.1. Capsules Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
9.4. Injectable
9.4.1. Injectable Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
9.5. Sprays
9.5.1. Sprays Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
9.6. Suspensions
9.6.1. Suspensions Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
9.7. Powders
9.7.1. Powders Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
9.8. Other Formulations
9.8.1. Other Formulations Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
Chapter 10. Pharmaceutical Market: Age Group Estimates & Trend Analysis
10.1. Pharmaceutical Market: Age Group Movement Analysis
10.2. Children & Adolescents
10.2.1. Children & Adolescents Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
10.3. Adults
10.3.1. Adults Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
10.4. Geriatric
10.4.1. Geriatric Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
Chapter 11. Pharmaceutical Market: End Market Estimates & Trend Analysis
11.1. Pharmaceutical Market: End Market Movement Analysis
11.2. Hospitals
11.2.1. Hospitals Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
11.3. Clinics
11.3.1. Clinics Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
11.4. Others
11.4.1. Others Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Billion)
Chapter 12. Pharmaceutical Market: Regional Business Analysis
12.1. Pharmaceutical Market Share By Region, 2022 & 2030
12.2. North America
12.2.1. North America Pharmaceutical market, 2018 – 2030 (USD Million)
12.2.2. U.S.
12.2.2.1. Key Country Dynamics
12.2.2.2. Target Disease Prevalence
12.2.2.3. Competitive Scenario
12.2.2.4. Regulatory Framework
12.2.2.5. Reimbursement Scenario
12.2.2.6. U.S. Pharmaceutical market, 2018 – 2030 (USD MILLION)
12.2.3. Canada
12.2.3.1. Key Country Dynamics
12.2.3.2. Target Disease Prevalence
12.2.3.3. Competitive Scenario
12.2.3.4. Regulatory Framework
12.2.3.5. Reimbursement Scenario
12.2.3.6. Canada Pharmaceutical market, 2018 – 2030 (USD Million)
12.3. Europe
12.3.1. Europe Pharmaceutical market, 2018 – 2030 (USD Million)
12.3.2. Germany
12.3.2.1. Key Country Dynamics
12.3.2.2. Target Disease Prevalence
12.3.2.3. Competitive Scenario
12.3.2.4. Regulatory Framework
12.3.2.5. Reimbursement Scenario
12.3.2.6. Germany Pharmaceutical market, 2018 – 2030 (USD Million)
12.3.3. UK
12.3.3.1. Key Country Dynamics
12.3.3.2. Target Disease Prevalence
12.3.3.3. Competitive Scenario
12.3.3.4. Regulatory Framework
12.3.3.5. Reimbursement Scenario
12.3.3.6. UK Pharmaceutical market, 2018 – 2030 (USD Million)
12.3.4. France
12.3.4.1. Key Country Dynamics
12.3.4.2. Target Disease Prevalence
12.3.4.3. Competitive Scenario
12.3.4.4. Regulatory Framework
12.3.4.5. Reimbursement Scenario
12.3.4.6. France Pharmaceutical market, 2018 – 2030 (USD Million)
12.3.5. Italy
12.3.5.1. Key Country Dynamics
12.3.5.2. Target Disease Prevalence
12.3.5.3. Competitive Scenario
12.3.5.4. Regulatory Framework
12.3.5.5. Reimbursement Scenario
12.3.5.6. Italy Pharmaceutical market, 2018 – 2030 (USD Million)
12.3.6. Spain
12.3.6.1. Key Country Dynamics
12.3.6.2. Target Disease Prevalence
12.3.6.3. Competitive Scenario
12.3.6.4. Regulatory Framework
12.3.6.5. Reimbursement Scenario
12.3.6.6. Spain Pharmaceutical market, 2018 – 2030 (USD Million)
12.3.7. Denmark
12.3.12.1. Key Country Dynamics
12.3.12.2. Target Disease Prevalence
12.3.12.3. Competitive Scenario
12.3.12.4. Regulatory Framework
12.3.12.5. Reimbursement Scenario
12.3.12.6. Denmark Pharmaceutical market, 2018 – 2030 (USD Million)
12.3.8. Sweden
12.3.8.1. Key Country Dynamics
12.3.8.2. Target Disease Prevalence
12.3.8.3. Competitive Scenario
12.3.8.4. Regulatory Framework
12.3.8.5. Reimbursement Scenario
12.3.8.6. Sweden Pharmaceutical market, 2018 – 2030 (USD Million)
12.3.9. Norway
12.3.9.1. Key Country Dynamics
12.3.9.2. Target Disease Prevalence
12.3.9.3. Competitive Scenario
12.3.9.4. Regulatory Framework
12.3.9.5. Reimbursement Scenario
12.3.9.6. Norway Pharmaceutical market, 2018 – 2030 (USD Million)
12.4. Asia Pacific
12.4.1. Asia Pacific Pharmaceutical market, 2018 – 2030 (USD Million)
12.4.2. Japan
12.4.2.1. Key Country Dynamics
12.4.2.2. Target Disease Prevalence
12.4.2.3. Competitive Scenario
12.4.2.4. Regulatory Framework
12.4.2.5. Reimbursement Scenario
12.4.2.6. Japan Pharmaceutical market, 2018 – 2030 (USD Million)
12.4.3. China
12.4.3.1. Key Country Dynamics
12.4.3.2. Target Disease Prevalence
12.4.3.3. Competitive Scenario
12.4.3.4. Regulatory Framework
12.4.3.5. Reimbursement Scenario
12.4.3.6. China Pharmaceutical market, 2018 – 2030 (USD Million)
12.4.4. India
12.4.4.1. Key Country Dynamics
12.4.4.2. Target Disease Prevalence
12.4.4.3. Competitive Scenario
12.4.4.4. Regulatory Framework
12.4.4.5. Reimbursement Scenario
12.4.4.6. India Pharmaceutical market, 2018 – 2030 (USD Million)
12.4.5. South Korea
12.4.5.1. Key Country Dynamics
12.4.5.2. Target Disease Prevalence
12.4.5.3. Competitive Scenario
12.4.5.4. Regulatory Framework
12.4.5.5. Reimbursement Scenario
12.4.5.6. South Korea Pharmaceutical market, 2018 – 2030 (USD Million)
12.4.6. Australia
12.4.6.1. Key Country Dynamics
12.4.6.2. Target Disease Prevalence
12.4.6.3. Competitive Scenario
12.4.6.4. Regulatory Framework
12.4.6.5. Reimbursement Scenario
12.4.6.6. Australia Pharmaceutical market, 2018 – 2030 (USD Million)
12.4.7. Thailand
12.4.7.1. Key Country Dynamics
12.4.7.2. Target Disease Prevalence
12.4.7.3. Competitive Scenario
12.4.7.4. Regulatory Framework
12.4.7.5. Reimbursement Scenario
12.4.7.6. Thailand Pharmaceutical market, 2018 – 2030 (USD Million)
12.5. Latin America
12.5.1. Latin America Pharmaceutical market, 2018 – 2030 (USD Million)
12.5.2. Brazil
12.5.2.1. Key Country Dynamics
12.5.2.2. Target Disease Prevalence
12.5.2.3. Competitive Scenario
12.5.2.4. Regulatory Framework
12.5.2.5. Reimbursement Scenario
12.5.2.6. Brazil Pharmaceutical market, 2018 – 2030 (USD Million)
12.5.3. Mexico
12.5.3.1. Key Country Dynamics
12.5.3.2. Target Disease Prevalence
12.5.3.3. Competitive Scenario
12.5.3.4. Regulatory Framework
12.5.3.5. Reimbursement Scenario
12.5.3.6. Mexico Pharmaceutical market, 2018 – 2030 (USD Million)
12.5.4. Argentina
12.5.4.1. Key Country Dynamics
12.5.4.2. Target Disease Prevalence
12.5.4.3. Competitive Scenario
12.5.4.4. Regulatory Framework
12.5.4.5. Reimbursement Scenario
12.5.4.6. Argentina Pharmaceutical market, 2018 – 2030 (USD Million)
12.6. MEA
12.6.1. MEA Pharmaceutical market, 2018 – 2030 (USD Million)
12.6.2. South Africa
12.6.2.1. Key Country Dynamics
12.6.2.2. Target Disease Prevalence
12.6.2.3. Competitive Scenario
12.6.2.4. Regulatory Framework
12.6.2.5. Reimbursement Scenario
12.6.2.6. South Africa Pharmaceutical market, 2018 – 2030 (USD Million)
12.6.3. Saudi Arabia
12.6.3.1. Key Country Dynamics
12.6.3.2. Target Disease Prevalence
12.6.3.3. Competitive Scenario
12.6.3.4. Regulatory Framework
12.6.3.5. Reimbursement Scenario
12.6.3.6. Saudi Arabia Pharmaceutical market, 2018 – 2030 (USD Million)
12.6.4. UAE
12.6.4.1. Key Country Dynamics
12.6.4.2. Target Disease Prevalence
12.6.4.3. Competitive Scenario
12.6.4.4. Regulatory Framework
12.6.4.5. Reimbursement Scenario
12.6.4.6. UAE Pharmaceutical market, 2018 – 2030 (USD Million)
12.6.5. Kuwait
12.6.5.1. Key Country Dynamics
12.6.5.2. Target Disease Prevalence
12.6.5.3. Competitive Scenario
12.6.5.4. Regulatory Framework
12.6.5.5. Reimbursement Scenario
12.6.5.6. Kuwait Pharmaceutical market, 2018 – 2030 (USD Million)
Chapter 13. Competitive Landscape
13.1. Company Categorization
13.2. Strategy Mapping
13.2.1. New Product Launch
13.2.2. Partnerships
13.2.3. Acquisition
13.2.4. Collaboration
13.2.5. Funding
13.3. Key Company Market Share Analysis, 2022
13.4. Company Heat Map Analysis
13.5. Company Profiles
13.5.1. F. HOFFMANN – LA ROCHE LTD.
13.5.1.1. Company Overview
13.5.1.2. Financial Performance
13.5.1.3. Product Benchmarking
13.5.1.4. Strategic Initiatives
13.5.2. NOVARTIS AG
13.5.2.1. Company Overview
13.5.2.2. Financial Performance
13.5.2.3. Product Benchmarking
13.5.2.4. Strategic Initiatives
13.5.3. ABBVIE INC.
13.5.3.1. Company Overview
13.5.3.2. Financial Performance
13.5.3.3. Product Benchmarking
13.5.3.4. Strategic Initiatives
13.5.4. JOHNSON & JOHNSON SERVICES, INC.
13.5.4.1. Company Overview
13.5.4.2. Financial Performance
13.5.4.3. Product Benchmarking
13.5.4.13. Strategic Initiatives
13.5.5. MERCK & CO., INC.
13.5.5.1. Company Overview
13.5.5.2. Financial Performance
13.5.5.3. Product Benchmarking
13.5.5.4. Strategic Initiatives
13.5.6. PFIZER INC.
13.5.6.1. Company Overview
13.5.6.2. Financial Performance
13.5.6.3. Product Benchmarking
13.5.6.4. Strategic Initiatives
13.5.7. BRISTOL – MYERS SQUIBB COMPANY
13.5.7.1. Company Overview
13.5.7.2. Financial Performance
13.5.7.3. Product Benchmarking
13.5.7.4. Strategic Initiatives
13.5.8. SANOFI
13.5.8.1. Company Overview
13.5.8.2. Financial Performance
13.5.8.3. Product Benchmarking
13.5.8.4. Strategic Initiatives
13.5.9. GSK PLC
13.5.9.1. Company Overview
13.5.9.2. Financial Performance
13.5.9.3. Product Benchmarking
13.5.9.4. Strategic Initiatives
13.5.10. TAKEDA PHARMACEUTICAL COMPANY LIMITED
13.5.10.1. Company Overview
13.5.10.2. Financial Performance
13.5.10.3. Product Benchmarking
13.5.10.4. Strategic Initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 4 Global Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 5 Global Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 6 Global Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 7 Global Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 8 Global Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 9 Global Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 10 Global Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 11 North America Pharmaceutical Market, By Country, 2018 - 2030 (USD Billion)
Table 12 North America Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 13 North America Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 14 North America Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 15 North America Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 16 North America Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 17 North America Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 18 North America Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 19 North America Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 20 U.S. Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 21 U.S. Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 22 U.S. Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 23 U.S. Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 24 U.S. Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 25 U.S. Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 26 U.S. Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 27 U.S. Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 28 Canada Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 29 Canada Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 30 Canada Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 31 Canada Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 32 Canada Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 33 Canada Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 34 Canada Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 35 Canada Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 36 Europe Pharmaceutical Market, By Country, 2018 - 2030 (USD Billion)
Table 37 Europe Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 38 Europe Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 39 Europe Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 40 Europe Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 41 Europe Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 42 Europe Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 43 Europe Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 44 Europe Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 45 UK Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 46 UK Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 47 UK Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 48 UK Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 49 UK Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 50 UK Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 51 UK Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 52 UK Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 53 Germany Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 54 Germany Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 55 Germany Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 56 Germany Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 57 Germany Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 58 Germany Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 59 Germany Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 60 Germany Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 61 France Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 62 France Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 63 France Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 64 France Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 65 France Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 66 France Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 67 France Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 68 France Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 69 Italy Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 70 Italy Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 71 Italy Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 72 Italy Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 73 Italy Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 74 Italy Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 75 Italy Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 76 Italy Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 77 Spain Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 78 Spain Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 79 Spain Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 80 Spain Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 81 Spain Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 82 Spain Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 83 Spain Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 84 Spain Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 85 Denmark Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 86 Denmark Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 87 Denmark Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 88 Denmark Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 89 Denmark Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 90 Denmark Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 91 Denmark Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 92 Denmark Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 93 Sweden Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 94 Sweden Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 95 Sweden Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 96 Sweden Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 97 Sweden Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 98 Sweden Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 99 Sweden Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 100 Sweden Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 101 Norway Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 102 Norway Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 103 Norway Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 104 Norway Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 105 Norway Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 106 Norway Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 107 Norway Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 108 Norway Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 109 Asia Pacific Pharmaceutical Market, By Country, 2018 - 2030 (USD Billion)
Table 110 Asia Pacific Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 111 Asia Pacific Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 112 Asia Pacific Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 113 Asia Pacific Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 114 Asia Pacific Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 115 Asia Pacific Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 116 Asia Pacific Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 117 Asia Pacific Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 118 Japan Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 119 Japan Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 120 Japan Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 121 Japan Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 122 Japan Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 123 Japan Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 124 Japan Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 125 Japan Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 126 China Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 127 China Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 128 China Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 129 China Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 130 China Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 131 China Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 132 China Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 133 China Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 134 India Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 135 India Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 136 India Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 137 India Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 138 India Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 139 India Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 140 India Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 141 India Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 142 South Korea Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 143 South Korea Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 144 South Korea Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 145 South Korea Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 146 South Korea Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 147 South Korea Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 148 South Korea Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 149 South Korea Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 150 Australia Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 151 Australia Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 152 Australia Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 153 Australia Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 154 Australia Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 155 Australia Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 156 Australia Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 157 Australia Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 158 Thailand Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 159 Thailand Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 160 Thailand Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 161 Thailand Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 162 Thailand Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 163 Thailand Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 164 Thailand Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 165 Thailand Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 166 Latin America Pharmaceutical Market, By Country, 2018 - 2030 (USD Billion)
Table 167 Latin America Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 168 Latin America Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 169 Latin America Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 170 Latin America Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 171 Latin America Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 172 Latin America Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 173 Latin America Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 174 Latin America Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 175 Brazil Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 176 Brazil Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 177 Brazil Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 178 Brazil Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 179 Brazil Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 180 Brazil Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 181 Brazil Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 182 Brazil Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 183 Mexico Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 184 Mexico Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 185 Mexico Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 186 Mexico Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 187 Mexico Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 188 Mexico Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 189 Mexico Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 190 Mexico Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 191 Argentina Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 192 Argentina Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 193 Argentina Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 194 Argentina Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 195 Argentina Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 196 Argentina Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 197 Argentina Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 198 Argentina Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 199 Middle East & Africa Pharmaceutical Market, By Country, 2018 - 2030 (USD Billion)
Table 200 Middle East & Africa Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 201 Middle East & Africa Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 202 Middle East & Africa Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 203 Middle East & Africa Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 204 Middle East & Africa Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 205 Middle East & Africa Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 206 Middle East & Africa Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 207 Middle East & Africa Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 208 Saudi Arabia Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 209 Saudi Arabia Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 210 Saudi Arabia Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 211 Saudi Arabia Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 212 Saudi Arabia Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 213 Saudi Arabia Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 214 Saudi Arabia Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 215 Saudi Arabia Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 216 South Africa Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 217 South Africa Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 218 South Africa Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 219 South Africa Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 220 South Africa Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 221 South Africa Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 222 South Africa Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 223 South Africa Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 224 UAE Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 225 UAE Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 226 UAE Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 227 UAE Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 228 UAE Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 229 UAE Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 230 UAE Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 231 UAE Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)
Table 232 Kuwait Pharmaceutical Market, By Molecule Type, 2018 - 2030 (USD Billion)
Table 233 Kuwait Pharmaceutical Market, By Product, 2018 - 2030 (USD Billion)
Table 234 Kuwait Pharmaceutical Market, By Type, 2018 - 2030 (USD Billion)
Table 235 Kuwait Pharmaceutical Market, By Diseases, 2018 - 2030 (USD Billion)
Table 236 Kuwait Pharmaceutical Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 237 Kuwait Pharmaceutical Market, By Formulation, 2018 - 2030 (USD Billion)
Table 238 Kuwait Pharmaceutical Market, By Age Group, 2018 - 2030 (USD Billion)
Table 239 Kuwait Pharmaceutical Market, By End Market, 2018 - 2030 (USD Billion)

※본 조사보고서 [세계의 의약품 시장 (2023-2030) : 분자 유형별, 제품별, 종류별, 질환별, 제형별, 연령대별, 투여 경로별, 최종 시장별, 지역별] (코드 : GRV24JNU037) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 의약품 시장 (2023-2030) : 분자 유형별, 제품별, 종류별, 질환별, 제형별, 연령대별, 투여 경로별, 최종 시장별, 지역별] 에 대해서 E메일 문의는 여기를 클릭하세요.

*** 아래는 관련 보고서 소개입니다 ***

세계의 스팀 오토클레이브 시장 (2023-2030) : 구성별 (수직, 수평), 용도별 (의료, 치과), 지역별
GRV23NOV244 / Grand View Research / 2023년 9월 / 글로벌 스팀 오토클레이브 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 스팀 오토클레이브 시장은 2030년까지 24억 3천만 달러에 달할 것으로 예상되며, 2023년부터 2030년까지 9. 90%의 CAGR로 성장할 것으로...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변동, 동향, 범위 Chapter 4. 세계의 스팀 오토클레이브 시장 : 구성 요소별 예측 및 동향 분석 Chapter 5. 세계의 스팀 오토클레이브 시장 : 용도별 예측 및 동향 분석 Chapter 6. 세계의 스팀 오토클레이브 시장 : 지역별 예측 및...

세계의 바이오 의약품 첨가제 시장 (2023-2030) : 제품별 (폴리올, 가용화제 및 계면활성제/유화제, 탄수화물, 특수 부형제), 지역별
GRV23NOV054 / Grand View Research / 2023년 9월 / 글로벌 바이오 의약품 첨가제 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 바이오 의약품 첨가제 시장 규모는 2030년까지 37. 6억 달러에 달할 것으로 예상되며, 2023년부터 2030년까지 연평균 5....Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변수, 동향 및 범위 Chapter 4. 세계의 바이오 의약품 첨가제 시장 : 제품별 분석 Chapter 5. 세계의 바이오 의약품 첨가제 시장 : 지역별 분석 Chapter 6. 세계의 바이오 의약품 첨가제 시장 : 경쟁 현황 Chapter 7. KOL 권고사항/애널리스트...

세계의 자동 조제기 시장 (2023-2030) : 용도별 (외래 환자, 입원 환자), 용도별 (병원, 소매 약국 및 약국), 운영별, 지역별
GRV23NOV048 / Grand View Research / 2023년 9월 / 글로벌 자동 조제기 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 자동 조제기 시장 규모는 2023년부터 2030년까지 연평균 7. 2%의 성장률을 기록해 2030년에는 831억 달러에 이를 것으로 전망됩니다....Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 세계의 자동 조제기 시장 변수/동향/범위 Chapter 4. 세계의 자동 조제기 시장 : 용도별 예측 및 동향 분석 Chapter 5. 세계의 자동 조제기 시장 : 최종 용도별 예측 및 동향 분석 Chapter 6. 세계의 자동 조제기 시장 : 운영별 예측...

세계의 심부전용 POC 및 LOC 기기 시장 (2023-2030) : 테스트 유형별, 기술별 (미세 유체 공학, 어레이 기반 시스템), 용도별 (클리닉, 병원, 생활 보조 의료 시설), 지역별
GRV23NOV129 / Grand View Research / 2023년 9월 / 글로벌 심부전용 POC 및 LOC 기기 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 심부전용 POC 및 LOC 기기 시장 규모는 2030년까지 284. 9백만 달러에 달할 것으로 예상되며,...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 세계의 심부전용 POC 및 LOC 기기 시장 변수/동향/범위 Chapter 4. 세계의 심부전용 POC 및 LOC 기기 시장 : 검사 종류별 예측 및 동향 분석 Chapter 5. 세계의 심부전용 POC 및 LOC 기기 시장 : 기술별 예측 및 동향 분석...

세계의 로봇 보조 내시경 시장 (2023-2030) : 최종 용도별 (병원, 외래 환자 시설), 지역별 (북미, 아시아 태평양, 유럽, 중남미, 중동 및 아프리카)
GRV23NOV241 / Grand View Research / 2023년 9월 / 글로벌 로봇 보조 내시경 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 로봇 보조 내시경 시장 규모는 2023년부터 2030년까지 연평균 8. 2%의 성장률을 기록하여 2030년에는 23억 6천만 달러에...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변동, 동향, 범위 Chapter 4. 세계의 로봇 보조 내시경 시장 : 최종 용도별 예측 및 동향 분석 Chapter 5. 세계의 로봇 보조 내시경 시장 : 지역별 예측 및 동향 분석 Chapter 6. 경쟁 현황...

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!